← Company intelligence

Robot maker · registered

Medtronic (Surgical Robotics)

Corporate marketmedicalCurated record

Scoped entry: covers only Medtronic's surgical robotics program (Hugo RAS soft-tissue platform and Mazor X Stealth Edition spine robotics). Jobs, news and milestones are filtered to these product lines; Medtronic-wide business data (revenue, funding, headcount) is not tracked.

Scoped entry for the surgical robotics program of diversified medtech giant Medtronic (operational HQ Minneapolis, Minnesota; legal HQ Galway, Ireland). Hugo RAS is a modular, multi-quadrant teleoperated soft-tissue surgery platform combining wristed instruments, 3D visualization and the Touch Surgery Enterprise surgical-video/AI ecosystem; first-in-world procedure June 2021 in Chile, CE-marked, and FDA-cleared for urologic procedures (prostatectomy, nephrectomy, cystectomy) in December 2025 with the first US commercial case at Cleveland Clinic in February 2026. Mazor X Stealth Edition (from the 2018 Mazor Robotics acquisition) combines pre-operative planning software, robotic guidance and Stealth navigation for spine surgery. In June 2026 Medtronic submitted 510(k)s to expand Hugo into general and gynecologic surgery.

HeadquartersMinneapolis, US
Founded1949
Corporate fundingNot disclosed
TeamNot listed
Deployments2
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StagePublic (NYSE: MDT); no program-specific external funding
FoundersEarl Bakken (Co-Founder), Palmer Hermundslie (Co-Founder)
Regions servedNorth America, Europe, Latin America, Asia-Pacific, Middle East
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-21
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Hugo RAS System

  • Modular, multi-quadrant robotic-assisted surgery platform with wristed instruments, 3D visualization and Touch Surgery Enterprise video capture

    System architecture and capabilities as described by Medtronic at first-in-world procedure

    Claim source
  • FDA 510(k)-cleared for minimally invasive urologic procedures including prostatectomy, nephrectomy and cystectomy, validated in the 137-patient Expand URO IDE study

    US regulatory clearance scope and pivotal-trial basis

    Claim source
Machinemedical

Mazor X Stealth Edition

  • Spine surgery platform combining pre-operative planning software, robotic guidance arm and integrated Stealth navigation for precise pedicle screw placement

    Platform capabilities as described in peer-reviewed technical literature

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-02-17Cleveland Clinichospital (first US commercial Hugo RAS case, robotic-assisted prostatectomy)USNot disclosedAnnouncement
2021-06-22Clinica Santa Mariahospital (first-in-world Hugo RAS procedure, robotic prostatectomy)CLNot disclosedAnnouncement
TL

Company timeline

Milestones and announcements

2026-02-17First US commercial Hugo RAS surgery performed at Cleveland Clinic by Dr. Jihad KaoukMedtronic
2025-12-03FDA clearance of the Hugo RAS system for urologic surgical procedures, opening the US market (~230,000 urologic surgeries/year)Medtronic
2021-06-22First-in-world patient procedure with the Hugo RAS system (robotic prostatectomy) performed at Clinica Santa Maria, Santiago, ChileMedtronic
SC

Source ledger

5 unique public sources

Record / medtronic-surgical-roboticsLast reviewed / 2026-07-215 sourcesMachine-readable